Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Locations
Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
BGB-A317-213
Recruiting
Study of Tislelizumab in Participants With Resectable Esophageal Squamous Cell Carcinoma
Beigene Study ID
BGB-A317-213
ClinicalTrials.gov ID
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents